Photo of Miguel N. Rivera, MD

Miguel N. Rivera, MD

  • Assistant Molecular Pathologist, Massachusetts General Hospital
  • Assistant Professor of Pathology, Harvard Medical School


Accepting New Patients

E-mail me Visit my website


Dr. Rivera is the attending physician in the Center for Integrated Diagnostics. He is also affiliated with the kidney cancer program at Dana-Farber / Harvard Cancer Center.



Clinical Interests
  • Molecular pathology
Medical Education
  • MD, Harvard Medical School
  • Residency, Brigham and Women's Hospital
Board Certifications
  • Anatomic Pathology
  • Molecular Genetic Pathology
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group

Edit Profile


Dr. Rivera is a board certified pathologist who directs a research laboratory at the MGH Department of Pathology and the MGH Cancer Center. He also serves as attending physician in the clinical molecular diagnostics laboratory at MGH. Dr. Rivera received an A.B. in Molecular Biology from Princeton University in 1996 and an M.D. from Harvard Medical School in 2001. He completed his Anatomic Pathology residency at Brigham and Wome?s Hospital and a fellowship in Molecular Diagnostics at the Harvard Combined Program. During his postdoctoral fellowship, Dr. Rivera identified the tumor suppressor gene WTX which is implicated in both tumor formation and stem cell biology. His research currently focuses on the connections between cancer and normal developmental processes and on the use of genomic technologies to identify pathways that are active in tumors and that may serve as therapeutic targets.

Edit Profile

Research & Publications

Research Summary

Our laboratory uses genomic technologies to identify and characterize pathways implicated in pediatric solid tumors and sarcomas. Read more about the Rivera Lab.


Selected Publications:

Rivera MN, Kim WJ, Wells J, Stone A, Burger A, Coffman EJ, Zhang J, Haber DA (2009). The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity. Proceedings of the National Academy of Sciences U S A, 106(20):8338-43.

Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, Kim JC, Feinberg AP, Gerald WL, Vargas SO, Chin L, Iafrate AJ, Bell DW, Haber DA (2007). An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science, 315: 642-5.

Rivera MN, Haber DA (2005) Wilms tumor: connecting tumorigenesis and organ development in the kidney. Nature Reviews Cancer, 5(9):699-712.

Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C (2004). Detection of large-scale variation in the human genome. Nature Genetics, 36(9):949-51.

Edit Profile

News & Events


Pathology Associates
55 Fruit Street
Boston MA, 02114-2696
Phone: 617-726-2967

Edit Profile

Back to Top